Founded in 1963, the Garvan Institute of Medical Research is a Sydney-based institute dedicated to genomic and cellular research aimed at advancing human health. With approximately 750 researchers and support staff, it operates within a collaborative ecosystem that brings together world-leading researchers and clinicians to tackle fundamental questions in medical science.
The institute's research output is substantial: in 2024 alone, Garvan produced 412 publications and had 20 clinical trials running. Its core technical domains - genomic research and cellular research - position it at the forefront of efforts to translate molecular insights into clinical outcomes across disease areas including cancer, diabetes, immunology, and neuroscience.
Garvan's work spans the full pipeline from discovery science to clinical translation, reflecting a commitment to research that is both rigorous and consequential. For professionals seeking an environment where scientific excellence is the norm and where research has a direct pathway to patient impact, Garvan represents one of Australia's leading research institutions.
